[Immunotherapy in urology: Concept and results].
CONCLUSION: Immunotherapy is a key treatment in kidney and bladder cancer. In the future, the identification of predictive markers should allow us to better select patients responding to immunotherapy.
PMID: 31477432 [PubMed - as supplied by publisher]
Source: Progres en Urologie - Category: Urology & Nephrology Tags: Prog Urol Source Type: research
More News: Bladder Cancer | Cancer | Cancer & Oncology | Carcinoma | Conferences | Immunotherapy | Kidney Cancer | Neoadjuvant Therapy | Prostate Cancer | Renal Cell Carcinoma | Urology & Nephrology